Ashley Paul Hancock

Person

Stevenage, GB

People

Patents Grantslast 30 patents

Information Patent Grant
1,3 di-substituted cyclobutane or azetidine derivatives as hematopo...
- Patent number 11,053,234
- Issue date Jul 6, 2021
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
- David Norman Deaton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Naphthyridine derivatives as alpha V beta 6 integrin antagonists fo...
- Patent number 10,513,517
- Issue date Dec 24, 2019
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Naphthyridines as integrin antagonists
- Patent number 10,487,080
- Issue date Nov 26, 2019
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds αvβ6 integrin antagonists
- Patent number 10,342,783
- Issue date Jul 9, 2019
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Naphthyridine derivatives as alpha v beta 6 integrin antagonists fo...
- Patent number 10,144,733
- Issue date Dec 4, 2018
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds alpha v beta 6 integrin antagonists
- Patent number 10,004,724
- Issue date Jun 26, 2018
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds αvβ6 integrin antagonists
- Patent number 10,000,489
- Issue date Jun 19, 2018
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds αv β6 integrin antagonists
- Patent number 9,956,209
- Issue date May 1, 2018
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds
- Patent number 7,884,114
- Issue date Feb 8, 2011
- Glaxo Group Limited
- Paul Martin Gore
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CHEMICAL COMPOUNDS
- Publication number 20210238162
- Publication date Aug 5, 2021
- GlaxoSmithKline Intellectual Property Development Limited
- Rodolfo CADILLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS
- Publication number 20210206758
- Publication date Jul 8, 2021
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew ANDERSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS avB6 INTEGRIN ANTAGONISTS.
- Publication number 20190275016
- Publication date Sep 12, 2019
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPO...
- Publication number 20190241554
- Publication date Aug 8, 2019
- GlaxoSmithKline Intellectual Property Development Limited
- David Norman DEATON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS
- Publication number 20190112306
- Publication date Apr 18, 2019
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINE DERIVATIVES AS ALPHA V BETA 6 INTEGRIN ANTAGONISTS FO...
- Publication number 20190048005
- Publication date Feb 14, 2019
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew ANDERSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
- Publication number 20180271845
- Publication date Sep 27, 2018
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
- Publication number 20170298063
- Publication date Oct 19, 2017
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
- Publication number 20170290817
- Publication date Oct 12, 2017
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew Anderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
- Publication number 20170290818
- Publication date Oct 12, 2017
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew ANDERSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NAPHTHYRIDINE DERIVATIVES AS ALPHA V BETA 6 INTEGRIN ANTAGONISTS FO...
- Publication number 20170291899
- Publication date Oct 12, 2017
- GlaxoSmithKline Intellectual Property Development Limited
- Niall Andrew ANDERSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINOLINE DERIVATIVES AS H1 RECEPTOR ANTAGONISTS
- Publication number 20110281909
- Publication date Nov 17, 2011
- Glaxo Group Limited
- Paul Martin Gore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINOLINE DERIVATIVES USED TO TREAT INFLAMMATORY AND ALLERGIC DISEASES
- Publication number 20100222349
- Publication date Sep 2, 2010
- Glaxo Group Limited
- Paul Martin Gore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2....
- Publication number 20100075953
- Publication date Mar 25, 2010
- Glaxo Group Limited
- Rachael Ancliff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds
- Publication number 20090270355
- Publication date Oct 29, 2009
- Glaxo Group Limited
- Paul Martin Gore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Histamine Receptor Antagonists Comprising an Azepin Core
- Publication number 20090181950
- Publication date Jul 16, 2009
- Glaxo Group Limited
- Rachael Ann Ancliff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and...
- Publication number 20090105225
- Publication date Apr 23, 2009
- Glaxo Group Limited
- Paul Martin Gore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS
- Publication number 20080039444
- Publication date Feb 14, 2008
- Glaxo Group Limited
- Paul Martin GORE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds
- Publication number 20060293298
- Publication date Dec 28, 2006
- Mark James Bamford
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2....
- Publication number 20060025404
- Publication date Feb 2, 2006
- Rachel Ancliff
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds
- Publication number 20060019964
- Publication date Jan 26, 2006
- Ranchael Ann Ancliff
- C07 - ORGANIC CHEMISTRY

Ashley Paul Hancock

Person

Patents Grantslast 30 patents

1,3 di-substituted cyclobutane or azetidine derivatives as hematopo...

Naphthyridine derivatives as alpha V beta 6 integrin antagonists fo...

Naphthyridines as integrin antagonists

Compounds αvβ6 integrin antagonists

Naphthyridine derivatives as alpha v beta 6 integrin antagonists fo...

Compounds alpha v beta 6 integrin antagonists

Compounds αvβ6 integrin antagonists

Compounds αv β6 integrin antagonists

Compounds

Patents Applicationslast 30 patents

CHEMICAL COMPOUNDS

NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS

NOVEL COMPOUNDS avB6 INTEGRIN ANTAGONISTS.

1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPO...

NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS

NAPHTHYRIDINE DERIVATIVES AS ALPHA V BETA 6 INTEGRIN ANTAGONISTS FO...

NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS

NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS

NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS

NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS

NAPHTHYRIDINE DERIVATIVES AS ALPHA V BETA 6 INTEGRIN ANTAGONISTS FO...

SUBSTITUTED QUINOLINE DERIVATIVES AS H1 RECEPTOR ANTAGONISTS

QUINOLINE DERIVATIVES USED TO TREAT INFLAMMATORY AND ALLERGIC DISEASES

SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2....

Compounds

Histamine Receptor Antagonists Comprising an Azepin Core

2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and...

COMPOUNDS

Compounds

Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2....

Compounds